...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Data Expected September 2019 for BETonMACE Phase 3 Cardiovascular Outcomes Trial for Apabetalone

Free
Message: Vacepa new

It looks like this fish oil drug is working wonders for those taking it. (I started on it about two months ago and it cut my tryglicirides by 40% but it’s ultra expensive stuff.

Is this a boon or a bane or just not relevant for our BETOnMACE project that we are expecting to hear more about by July ‘19 (or later)

In the meantime not much to expect, except our long awaited wait for the promised additional funding discussed at the end of January.

Comments? (Up to $19 per share on the Vascepa parent)

3
Mar 19, 2019 04:01PM
4
Mar 19, 2019 04:16PM
2
Mar 19, 2019 05:32PM
2
Mar 19, 2019 05:46PM
6
Mar 19, 2019 05:58PM
3
Mar 19, 2019 08:14PM
Share
New Message
Please login to post a reply